- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FQ7: 2-[(3,5-dichlorophenyl)amino]benzoic acid(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
NA.2: 4 residues within 4Å:- Chain A: E.92, Y.116
- Chain B: E.92, Y.116
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:E.92, B:E.92, B:Y.116, A:E.92
- Water bridges: A:Y.116
NA.5: 4 residues within 4Å:- Chain C: E.92, Y.116
- Chain D: E.92, Y.116
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:E.92, D:Y.116, C:E.92, C:Y.116
- Water bridges: C:Y.116
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cody, V. et al., Structural Analysis of Human Transthyretin Analgesic Inhibitor Complex. To Be Published
- Release Date
- 2019-04-17
- Peptides
- Transthyretin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FQ7: 2-[(3,5-dichlorophenyl)amino]benzoic acid(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cody, V. et al., Structural Analysis of Human Transthyretin Analgesic Inhibitor Complex. To Be Published
- Release Date
- 2019-04-17
- Peptides
- Transthyretin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B